[HTML][HTML] Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger, T van Montfort… - Retrovirology, 2015 - Springer
Background Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
K Sliepen, G Ozorowski, JA Burger… - …, 2015 - search.ebscohost.com
Background: Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger… - …, 2015 - researchinformation.amsterdamumc …
Background: Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger, T Montfort… - Retrovirology, 2015 - infona.pl
Background Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
K Sliepen, G Ozorowski, JA Burger, T van Montfort… - …, 2015 - europepmc.org
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their
immunogenicity. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
immunogenicity. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
[PDF][PDF] Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger, T van Montfort… - 2015 - core.ac.uk
Background: Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
[PDF][PDF] Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger, T van Montfort… - 2015 - academia.edu
Background: Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings We describe ferritin-based protein …
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger… - …, 2015 - search.proquest.com
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their
immunogenicity Page 1 Sliepen et al. Retrovirology (2015) 12:82 DOI 10.1186/s12977-015-0210-4 …
immunogenicity Page 1 Sliepen et al. Retrovirology (2015) 12:82 DOI 10.1186/s12977-015-0210-4 …
[PDF][PDF] Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
K Sliepen, G Ozorowski, JA Burger, T van Montfort… - 2015 - researchgate.net
Background: Presenting vaccine antigens in particulate form can improve their
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …
immunogenicity by enhancing B cell activation. Findings: We describe ferritin-based protein …